{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:18:57Z","timestamp":1778635137713,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ygyno.2009.05.013","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T08:09:31Z","timestamp":1244275771000},"page":"390-394","source":"Crossref","is-referenced-by-count":61,"title":["Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma"],"prefix":"10.1016","volume":"114","author":[{"given":"Koen D.","family":"Quint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurits N.C.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan T.","family":"Geraets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim G.V.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta C.","family":"Pirog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.05.013_bib1","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","article-title":"Incidence trends of adenocarcinoma of the cervix in 13 European countries","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2009.05.013_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","article-title":"International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas","volume":"75","author":"Vizcaino","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.013_bib3","first-page":"1151","article-title":"Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women","volume":"164","author":"Liu","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.ygyno.2009.05.013_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses","volume":"153","author":"Kleter","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib5","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.35.3.791-795.1997","article-title":"A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings","volume":"35","author":"Jacobs","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","article-title":"GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes","volume":"40","author":"van den Brule","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma","volume":"157","author":"Pirog","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.285.1.47","article-title":"Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma","volume":"285","author":"Anttila","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2009.05.013_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.20257","article-title":"Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study","volume":"111","author":"Smith","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.013_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338569","article-title":"Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines","volume":"185","author":"Smith","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ygyno.2009.05.013_bib12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.22325","article-title":"Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors","volume":"120","author":"Madeleine","year":"2007","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.ygyno.2009.05.013_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ijc.10639","article-title":"A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma","volume":"101","author":"Wallin","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.013_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/aje\/kwi262","article-title":"Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents","volume":"162","author":"Samoff","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ijc.20970","article-title":"Chlamydia trachomatis infection and persistence of human papillomavirus","volume":"116","author":"Silins","year":"2005","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.ygyno.2009.05.013_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000156481","article-title":"Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways","volume":"51","author":"Paba","year":"2008","journal-title":"Intervirology"},{"key":"10.1016\/j.ygyno.2009.05.013_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2353\/jmoldx.2007.070011","article-title":"A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars","volume":"9","author":"Quint","year":"2007","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2009.05.013_bib18","series-title":"Blaustein's Pathology of the Female Genital Tract","first-page":"279","article-title":"Carcinoma and other tumors of the cervix","author":"Wright","year":"1994"},{"key":"10.1016\/j.ygyno.2009.05.013_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ygyno.2006.11.006","article-title":"Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix","volume":"105","author":"Zereu","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.pgp.0000157918.36354.c1","article-title":"Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia","volume":"24","author":"Xu","year":"2005","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/PAS.0b013e3181883722","article-title":"Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study","volume":"32","author":"Kawauchi","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/path.1480","article-title":"The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix","volume":"201","author":"Zielinski","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.bjc.6602915","article-title":"Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands","volume":"94","author":"Bulk","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.013_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2009.05.013_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/modpathol.3800316","article-title":"Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study","volume":"18","author":"An","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1525-1438.2006.00552.x","article-title":"Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients","volume":"16","author":"Tawfik El-Mansi","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.013_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s004280000277","article-title":"Differences in HPV 16- and HPV 18 E6\/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri","volume":"437","author":"Riethdorf","year":"2000","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2009.05.013_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004347-199704000-00004","article-title":"Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status","volume":"16","author":"Anciaux","year":"1997","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0046-8177(95)90065-9","article-title":"The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis","volume":"26","author":"Duggan","year":"1995","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1309\/97JHG6GLY69BVF4Y","article-title":"Frequency and outcome of cervical cancer prevention failures in the United States","volume":"128","author":"Raab","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.013_bib31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"HPV Vaccine Study group. Sustained efficacy up to 4.5\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2009.05.013_bib32","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ygyno.2007.08.059","article-title":"Human papillomavirus vaccines and the potential for cross-protection between related HPV types","volume":"107","author":"Ault","year":"2007","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809003461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809003461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:08:10Z","timestamp":1589879290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809003461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0090825809003461"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.05.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}